Biomnis (Legionellosis analysis division) Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 891

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Biomnis (Legionellosis analysis division) General Information

Description

Provider of testing and research services for legionellosis diseases. The company's research works and services include a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.

Contact Information

Formerly Known As
Marcel Mérieux Laboratory
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 17/19 Avenue Tony Garnier
  • 69007 Lyon
  • France
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 17/19 Avenue Tony Garnier
  • 69007 Lyon
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomnis (Legionellosis analysis division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomnis (Legionellosis analysis division)‘s full profile, request access.

Request a free trial

Biomnis (Legionellosis analysis division) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomnis (Legionellosis analysis division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomnis (Legionellosis analysis division)‘s full profile, request access.

Request a free trial

Biomnis (Legionellosis analysis division) FAQs

  • Where is Biomnis (Legionellosis analysis division) headquartered?

    Biomnis (Legionellosis analysis division) is headquartered in Lyon, France.

  • What is the size of Biomnis (Legionellosis analysis division)?

    Biomnis (Legionellosis analysis division) has 891 total employees.

  • What industry is Biomnis (Legionellosis analysis division) in?

    Biomnis (Legionellosis analysis division)’s primary industry is Laboratory Services (Healthcare).

  • Is Biomnis (Legionellosis analysis division) a private or public company?

    Biomnis (Legionellosis analysis division) is a Private company.

  • What is Biomnis (Legionellosis analysis division)’s current revenue?

    The current revenue for Biomnis (Legionellosis analysis division) is .

  • Who are Biomnis (Legionellosis analysis division)’s investors?

    Biomnis has invested in Biomnis (Legionellosis analysis division).

  • When was Biomnis (Legionellosis analysis division) acquired?

    Biomnis (Legionellosis analysis division) was acquired on 01-Jan-2010.

  • Who acquired Biomnis (Legionellosis analysis division)?

    Biomnis (Legionellosis analysis division) was acquired by Groupe Alpa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process